Himatsingka Seide's audit record is clean on its face, unqualified opinions every year from FY2020 through FY2026, but the underlying picture carries several layers of risk. Goodwill has been repeatedly inflated by currency moves rather than business performance, a series of stock-exchange fines point to governance lapses, and revenue is heavily concentrated in a handful of customers including a subsidiary. Borrowings understate the company's true obligations through recourse bill discounting and supplier finance, while tax demands have tripled on a new transfer-pricing adjustment.
Key findings
- Goodwill of ₹53,086 Lacs sits on the books after a ₹9,460.72 Lacs impairment, repeatedly inflated by rupee depreciation
Major- A ₹9,460.72 Lacs goodwill impairment was recognised in FY2024-25 as an exceptional item after the company decided not to renew license rights for certain brands. Consolidated goodwill rose by ₹699 Lacs to ₹53,086 Lacs in FY2023-24 and by ₹3,971 Lacs to ₹52,387 Lacs in FY2022-23, both "on account of the depreciation of Rupees against the US dollar". Auditors flagged goodwill impairment testing as a key audit matter in FY2020-21, FY2021-22, and FY2020, noting significant judgement including the impact of Covid-19. - Unqualified opinions every year, but audit-trail caveats at the database level since FY2024 and a FY2023 CARO mismatch on bank returns
Major- M S K A & Associates issued an unqualified opinion on the FY2026 financial statements, dated 27 May 2026. However, for FY2026 the auditor reported the audit trail was not enabled at the database level in SAP, and without a SOC report could not assess whether it existed or was tampered with. In FY2023, the CARO report stated quarterly returns filed with banks for working capital limits exceeded ₹5 crores were not in agreement with the books. - Stock-exchange fines for board-composition and governance lapses in FY2023 and FY2024, triggered by a lender's nominee director
Major- BSE and NSE each fined ₹6.60 lacs for non-compliance with Regulation 17(1) on board composition for the quarters ended March and June 2023, following Exim's nomination of Mr. Manish Krishnarao Joshi as nominee director effective March 9, 2023. The non-compliance persisted from March 9, 2023 until June 28, 2023, when Exim's nomination was withdrawn. BSE partially waived a fine of ₹1.82 lacs for the quarter ended June 2023 on June 24, 2024, and the FY2023-24 governance report stated no other penalties were imposed by stock exchanges, SEBI, or any statutory authority. - Revenue concentrated in a few customers, top customer a subsidiary, and receivables discounted with recourse
Major- In FY2025-26 standalone, three customers each contributed 10% or more of revenue: 42.49% from a subsidiary, 14.65%, and 10.48%. Trade receivables discounted with recourse and not derecognised stood at ₹33,579.88 Lacs as at 31 March 2022, down from ₹35,228.12 Lacs a year earlier. Revenue recognition was identified as a key audit matter in the consolidated financial statements for FY2021-22 and FY2020-21. - Contingent tax demands tripled in FY26 on a new ₹1,035.30 Lacs transfer-pricing adjustment
Minor- Contingent liabilities under the Income Tax Act rose to ₹1,453.75 Lacs as at 31 March 2026 from ₹418.45 Lacs a year earlier, driven by a new ₹1,035.30 Lacs disputed demand for AY 2021-22 on transfer pricing adjustments. An assessment order for AY 2023-24, received 31 March 2026, raised a demand of ₹14.17 crores, which the company is contesting. A separate order for AY 2022-23, received 9 April 2025, raised a demand of ₹65.46 crores. - Reported borrowings understate obligations through recourse bill discounting, supplier finance, and high-coupon private placements
Minor- Trade receivables discounted with recourse but not derecognised stood at ₹14,979.29 Lacs as at 31 March 2026, down from ₹20,121.44 Lacs a year earlier. The Board approved on 27 May 2026 issuance of NCDs up to ₹600 Crores at 11.50% p.a., following Series A NCDs of ₹65 Crores at 11.5% and Series B NCDs of ₹100 Crores at 11.00%. Supplier finance arrangements were first disclosed in FY2025-26 under amended Ind AS 7/107, with no comparative presented. - Inter-corporate loans to the loss-making North American subsidiary repeatedly converted to equity, with Indian plant assets pledged as security
Minor- Himatsingka Seide made an additional investment of ₹31,066.97 lacs in Himatsingka Holdings North America, Inc. during FY2020-21, including conversion of intercorporate loans to equity of ₹25,258.17 lacs. Security given to bankers for a loan taken by subsidiary Himatsingka America Inc. carried an outstanding balance of ₹1,629.22 lacs as at 31 March 2025, down from ₹4,748.44 lacs a year earlier, secured by a first pari passu charge on properties at Hassan and Doddaballapur plants. The loan balance was Nil as at 31 March 2026, and the corporate guarantee for the subsidiary was closed during FY2025-26. - Reported profit shaped by recurring estimates on useful lives and a planned FY27 switch to concessional tax rates
Minor- Effective 1 April 2019, the Company increased useful lives of certain property, plant and equipment based on a fresh technical assessment; depreciation for FY2019-20 would have been higher by ₹1,430.80 lacs had previous lives continued. The Company has not opted for the Section 115BAA concessional tax regime through FY2025-26, but expects to transition effective 1 April 2026. In FY2024-25, the Company applied a new tax rate of 25.168% versus 34.944% for measuring deferred tax, resulting in a reversal of deferred tax liabilities by ₹8,240 lacs.
What to watch
- AY 2023-24 tax appeal. The company is contesting a ₹14.17 crore demand from an assessment order received 31 March 2026.
- AY 2022-23 tax appeal. The company is contesting a ₹65.46 crore demand from an assessment order received 9 April 2025.
- Series 1 Listed NCD repayment. Principal of ₹300 Crores plus up to ₹250 Crores green shoe is due in three instalments at end of 30, 36 and 42 months from 25 August 2026.
- FCCB repayment. 50% of principal is due at end of 5 years from the first tranche issue date (26 April 2023), with the balance at end of 5 years 6 months, or conversion at holder's option.
- Tax regime transition. The switch to Section 115BAA concessional tax rates effective 1 April 2026 will impact deferred tax balances and the effective tax rate in FY2026-27 results.
Bottom line: This is a disclosed and audited record with unqualified opinions every year, but the risk sits in several places: goodwill that grows on currency moves rather than performance, governance fines tied to a lender's nominee, and a revenue base concentrated in a subsidiary. The borrowing picture is more complex than the balance sheet suggests, with recourse bill discounting, supplier finance, and high-coupon private placements. Watch the tax appeals and the NCD and FCCB repayment schedules.